“Transparency” has become one of the most overused words in pharmacy benefits. Nearly every PBM claims to be transparent. Marketing materials promise visibility and pass-through pricing. But when you...
As biosimilars continue entering the market at a rapid pace, plan sponsors have a growing opportunity to reduce pharmacy spend without compromising clinical outcomes. But capturing those savings is...
By Tracey Hamilton, AVP, Client Services, SlateRx When organizations evaluate a new pharmacy benefits partner or prepare for a transition, implementation is often viewed as a milestone, a date...
